Correct Answer: 2. Monitor for signs of depression and suicidal ideation
Core Clinical Concept
The therapeutic mechanism of pegylated interferon-α (PegIFN-α) involves broad systemic immune activation, which is directly responsible for its multisystem toxicities
[1]. Among these adverse reactions, neuropsychiatric disturbances—particularly depression—are among the most clinically significant and are a leading cause of dose modification or treatment discontinuation
[1]. While manic episodes are exceptionally rare, they represent a severe manifestation of this neuropsychiatric toxicity and require immediate recognition
[2]. Therefore, vigilant monitoring for mood changes, including depressive symptoms and suicidal ideation, is the highest priority nursing intervention to ensure patient safety during interferon therapy.
In-Depth Rationale
Why Monitoring for Depression and Suicidal Ideation is the Priority
Interferon-α induces neuropsychiatric symptoms not as a secondary or ancillary effect, but as a direct consequence of its immunomodulatory action. The systemic immune activation triggers a cascade of pro-inflammatory cytokines that cross the blood-brain barrier, altering neurotransmitter metabolism and neuroendocrine function
[1]. This pathophysiological mechanism explains why depression, anxiety, irritability, and sleep disturbances are so prevalent during treatment. The clinical significance of this toxicity is profound; it frequently necessitates dose reduction or outright cessation of a therapy that offers the potential for a functional cure of chronic hepatitis B
[1]. A case report further illustrates that the spectrum of interferon-induced neuropsychiatric events can extend to severe manifestations like a manic episode, even in patients with no prior psychiatric history, highlighting the unpredictable nature of this central nervous system toxicity
[2]. For the NCLEX-RN, this translates to a critical safety mandate: a baseline mental health assessment and ongoing, systematic screening for depression and suicidal ideation are non-negotiable components of the nursing care plan. Failure to identify these changes can lead to irreversible patient harm.
Analysis of Incorrect Options
1. Encourage increased fluid intake to prevent dehydration
While flu-like symptoms (fatigue, myalgia, fever) are a very common adverse effect of interferon therapy
[1], managing them is a supportive measure, not the highest priority. Hydration is important for comfort and to manage fever, but the life-threatening risk of major depression and suicide takes clear precedence in the hierarchy of nursing care. This option addresses a physiologic comfort need, whereas the correct answer addresses a psychosocial safety risk.
3. Administer acetaminophen for flu-like symptoms
This is a common and appropriate intervention to manage the anticipated flu-like syndrome caused by interferon
[1]. However, it is a dependent nursing intervention requiring a provider's order and is purely symptomatic management. The priority nursing action is the independent function of assessment, specifically monitoring for a severe, potentially fatal adverse reaction. The NCLEX consistently prioritizes assessment over implementation when both are plausible options.
4. Restrict physical activity to bed rest only
Fatigue is a documented toxicity of interferon therapy
[1], and energy conservation is a helpful strategy. However, strict bed rest is an extreme and outdated intervention that carries its own risks, such as deconditioning, venous thromboembolism, and muscle atrophy. A balanced approach of alternating activity with rest periods is more appropriate. This option is overly prescriptive and not supported as a primary safety intervention.
NCLEX-RN Test-Taking Strategy
This question tests the nursing process and the principle of prioritizing patient safety. When faced with multiple correct-sounding interventions, use Maslow’s hierarchy and the ABCs (Airway, Breathing, Circulation) as a framework, but remember that safety risks (like suicidal ideation) can supersede physical needs. The key is to distinguish between an expected side effect that requires management (flu-like symptoms) and a serious, life-threatening adverse reaction that requires immediate assessment and intervention (severe depression). The rationale from the provided sources confirms that neuropsychiatric toxicity is a direct, mechanism-based, and treatment-limiting consequence of interferon therapy, making its assessment the most critical nursing function
[1][2].
References (research sources)
- [1]
Mechanisms and management of pegylated interferon-α toxicity in chronic hepatitis B.Research articleZhu L, Peng F, Pi D, Lu J. (2026) · DOI: 10.3389/fimmu.2026.1801043
- [2]
Case Report: Probable manic episode induced by PEG-IFN <i>α</i>-2b in a chronic hepatitis B patient-multidisciplinary management insights.Case reportWu XC, Zhou H, Pang LT, Tang CL. (2026) · DOI: 10.3389/fmed.2026.1849394